What are the features and management of Orthodromic Atrioventricular Reentrant Tachycardia (OAVRT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Orthodromic Atrioventricular Reentrant Tachycardia (OAVRT): Features and Management

Orthodromic AVRT is a reentrant tachycardia in which the circuit uses the AV node for anterograde conduction and an accessory pathway for retrograde conduction from the ventricle to the atrium, typically presenting with a narrow QRS complex unless there is pre-existing bundle branch block or aberrant conduction. 1

Pathophysiology and Mechanism

Orthodromic AVRT is the most common form of atrioventricular reentrant tachycardia, accounting for approximately 90-95% of AVRT episodes in patients with accessory pathways 1. The reentrant circuit involves:

  • Anterograde conduction through the AV node and His-Purkinje system
  • Ventricular activation via normal conduction
  • Retrograde conduction through the accessory pathway back to the atrium
  • Completion of the circuit through atrial tissue back to the AV node

This creates a continuous electrical loop that sustains the tachycardia.

Clinical Presentation

Patients with orthodromic AVRT typically present with:

  • Paroxysmal palpitations
  • Light-headedness (common)
  • Chest discomfort
  • Fatigue during episodes
  • True syncope (infrequent but possible) 1

The rate of AVRT tends to be faster when induced during exercise, and women report more symptoms than men. Notably, 57% of patients with SVT experience episodes while driving, with 24% considering it an obstacle to driving 1.

ECG Features

Key ECG characteristics of orthodromic AVRT include:

  • Regular narrow QRS complex tachycardia (unless pre-existing bundle branch block is present)
  • Ventricular rate typically between 150-250 bpm
  • P waves visible in the early part of the ST-T segment (retrograde P waves)
  • RP interval shorter than PR interval ("short RP tachycardia") 1
  • RP interval typically <90 ms on surface ECG 1

This ECG pattern helps differentiate orthodromic AVRT from other SVTs, particularly AVNRT (where P waves are often buried in the QRS or appear as a pseudo-S wave in inferior leads).

Differential Diagnosis

Orthodromic AVRT must be distinguished from:

  • AVNRT (most common SVT)
  • Atrial tachycardia
  • Atypical AVNRT
  • Permanent form of junctional reciprocating tachycardia (PJRT) - a rare form of nearly incessant orthodromic AVRT involving a slowly conducting, concealed posteroseptal accessory pathway 1

Acute Management

For acute termination of orthodromic AVRT:

  1. First-line: Vagal maneuvers (Class I recommendation) 1
  2. Second-line: IV adenosine (highly effective with extremely short half-life) 2
  3. Alternative options:
    • IV calcium channel blockers (verapamil, diltiazem)
    • IV beta-blockers
    • Synchronized cardioversion for hemodynamically unstable patients

Long-term Management

Pharmacological Therapy

For prevention of recurrent episodes:

  • No single drug class stands out as therapy of choice 2
  • Options include:
    • Beta-blockers
    • Calcium channel blockers
    • Digitalis
    • Class IC antiarrhythmic drugs (flecainide, propafenone)
    • Class III antiarrhythmic drugs (sotalol, amiodarone)

Definitive Treatment

Catheter ablation is the definitive treatment of choice for symptomatic patients with AVRT. 1, 2

Catheter ablation:

  • High success rate (>95%)
  • Low complication rates
  • Special considerations for pathways in particular locations (e.g., septal region)
  • Cryoablation may be preferred for pathways close to normal conduction system 3

Special Considerations

Permanent Form of Junctional Reciprocating Tachycardia (PJRT)

  • A rare form of nearly incessant orthodromic AVRT
  • Involves a concealed accessory pathway with decremental conduction properties
  • Usually located in the posteroseptal region
  • ECG shows deeply inverted retrograde P waves in leads II, III, and aVF
  • Long RP interval due to the decremental conduction properties
  • May result in tachycardia-induced cardiomyopathy if left untreated 1

Wolff-Parkinson-White Syndrome

While orthodromic AVRT is the most common arrhythmia in WPW syndrome, these patients are at risk for:

  • Antidromic AVRT (rare, <5% of patients with WPW)
  • Pre-excited atrial fibrillation with risk of rapid ventricular response and sudden cardiac death 1, 3

Pitfalls and Caveats

  1. Misdiagnosis: Orthodromic AVRT can be misdiagnosed as AVNRT due to similar presentation with narrow complex tachycardia.

  2. Concealed pathways: Some accessory pathways conduct only in the retrograde direction (concealed) and do not show pre-excitation on the resting ECG, making diagnosis challenging 1.

  3. Bundle branch block: The presence of bundle branch block during orthodromic AVRT can make the QRS complex wide, potentially leading to misdiagnosis as ventricular tachycardia.

  4. Drug therapy caution: AV nodal blocking agents should be used with caution in patients with suspected pre-excitation, as they may facilitate rapid conduction through the accessory pathway during atrial fibrillation, potentially leading to ventricular fibrillation 1.

  5. Risk assessment: In patients with WPW syndrome and orthodromic AVRT, evaluation for risk of sudden cardiac death is important, particularly in those with shortest pre-excited R-R interval <250 ms during AF 1.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.